Cleared Traditional

AXIOS Stent and Electrocautery Enhanced Delivery System

K163272 · Boston Scientific Corporation · Gastroenterology & Urology
Feb 2017
Decision
89d
Days
Class 2
Risk

About This 510(k) Submission

K163272 is an FDA 510(k) clearance for the AXIOS Stent and Electrocautery Enhanced Delivery System, a Pancreatic Stent, Covered, Metallic, Removable (Class II — Special Controls, product code PCU), submitted by Boston Scientific Corporation (Marborough, US). The FDA issued a Cleared decision on February 18, 2017, 89 days after receiving the submission on November 21, 2016. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5015.

Submission Details

510(k) Number K163272 FDA.gov
FDA Decision Cleared SESE
Date Received November 21, 2016
Decision Date February 18, 2017
Days to Decision 89 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF

Device Classification

Product Code PCU — Pancreatic Stent, Covered, Metallic, Removable
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.5015
Definition To Facilitate Transmural Endoscopic Drainage Of Pancreatic Pseudocysts

Similar Devices — PCU Pancreatic Stent, Covered, Metallic, Removable

All 10
Niti-S SPAXUS Stent
K252648 · Taewoong Medical Co., Ltd. · Mar 2026
AXIOS Stent and Electrocautery-Enhanced Delivery System
K220112 · Boston Scientific Corporation · Sep 2022
AXIOS Stent and Electrocautery Enhanced Delivery System
K203132 · Boston Scientific Corporation · Apr 2021
AXIOS Stent and Electrocautery Enhanced Delivery System
K192043 · Boston Scientific Corporation · Aug 2019
AXIOS Stent and Delivery System, AXIOS Stent and Electrocautery Enhanced Delivery System
K181905 · Boston Scientific Corporation · Mar 2019
AXIOS Stent with Delivery System, AXIOS Stent with Electro-cautery Enhanced Delivery System
K153088 · Boston Scientific Corporation · Dec 2015